PharmiWeb.com - Global Pharma News & Resources
18-Jun-2024

Global Positive Air Pressure Devices Market Set for Significant Growth, Expected to Reach USD 4.7 Billion by 2032

The global positive air pressure devices market is projected to witness substantial growth over the forecast period, according to a new market research report by FMI. The report reveals that the market, which reached a valuation of USD 2.3 billion in 2021, is poised to achieve a valuation of USD 2.5 billion by the end of 2022. Furthermore, it is expected to surpass a market valuation of USD 4.7 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.4% during the period 2022-2032.

Positive air pressure devices, including continuous positive airways pressure (CPAP) devices and mechanical ventilators, are witnessing increased adoption globally due to their efficacy in treating medical conditions such as sleep apnea and respiratory failures. The continuous positive airways pressure devices segment dominated the market in 2021 with a share of about 71.4%, a trend expected to continue during the forecast period.

Get Sample Reports: https://www.futuremarketinsights.com/reports/sample/rep-gb-5623

The report highlights several factors contributing to this growth, including advancements in medical technology, an increase in the prevalence of sleep disorders, and a growing awareness of the benefits of positive air pressure therapy. Additionally, the rising incidence of respiratory conditions and the growing geriatric population are further driving the demand for these devices.

As healthcare systems worldwide continue to focus on improving patient outcomes, the adoption of positive air pressure devices is expected to grow, offering significant opportunities for manufacturers and stakeholders in the market.

Key findings from the report include:

  • The global positive air pressure devices market is expected to achieve a valuation of USD 2.5 Billion by the end of 2022.
  • The market is projected to witness a CAGR of 6.4% during the forecast period 2022-2032, surpassing a valuation of USD 4.7 Billion by 2032.
  • Continuous positive airways pressure (CPAP) devices are anticipated to maintain their dominance in the market throughout the forecast period.
  • Technological advancements and improvements in battery life are driving the adoption of mechanical ventilators.

Visit for Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-5623

Key Trends Driving the Positive Air Pressure Devices Market:

Rising Prevalence of Sleep Disorders and Respiratory Diseases:

  • Increasing cases of COPD and Obstructive Sleep Apnea (OSA) are fueling market growth.
  • Positive airway pressure therapy has shown effectiveness in treating these conditions, leading to higher demand for PAP devices.

Growing Geriatric Population:

  • OSA prevalence is higher in older adults, and PAP therapy can improve their independence and reduce healthcare costs.

Technological Advancements:

  • Introduction of new features like automatic pressure adjustment (APAP) and Bi-level Positive Airway Pressure (BiPAP) caters to diverse patient needs and drives market demand.

Improved Treatment Outcomes:

  • Studies show positive airway pressure therapy reduces hospitalizations for COPD and improves quality of life for OSA patients. This fosters market growth.

Key Companies Profiled:

  • 3B Medical, Inc
  • Hamilton Medical AG
  • BMC Medical Co. Ltd
  • Breas Medical AB
  • Compumedics Limited
  • Drive DeVilbiss Healthcare
  • Elmaslar Group
  • Fisher & Paykel Healthcare Corporation Limited
  • Hebei Topson Medical Technology Co., Ltd.
  • Kare Medical and Analytical Devices Ltd. Co
  • Koninklijke Philips N.V
  • Lowenstein Medical Technology GmbH.
  • Narang Medical Limited.
  • Somnetics International, Inc.
  • Draegerwerk AG & Co. KGaA
  • Apex Medical Corporation
  • ResMed Inc.

A Detailed Full Report: https://www.futuremarketinsights.com/checkout/5623

Key Market Segments Covered in Positive Air Pressure Devices Market Research:

By Product:

  • Continuous Positive Airways Pressure Devices (CPAP)
  • Bi-level Positive Airway Pressure (BiPAP)/ Variable Positive Airway Pressure (VPAP)
  • Automatic Positive Airway Pressure Devices (APAP)

By Application:

  • Obstructive sleep apnea
  • Respiratory failures
  • Others

By End User:

  • Hospitals
  • Clinics
  • Sleep Centers
  • Home care settings

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Editor Details

Last Updated: 18-Jun-2024